Hypoglycemic activity of Buchholzia coriacea (Capparaceae) seeds in streptozotocin-induced diabetic rats and mice

Experimental and Toxicologic Pathology

Volumn 63, Issue 7-8, 2011, Pages 619-625

  Adisa, Rahmat A ^a   Choudhary, Mohammed I ^b   Olorunsogo, Olufunso O ^a  

^a UNIVERSITY OF IBADAN   (Nigeria)

^b UNIVERSITY OF KARACHI   (Pakistan)

Author keywords

Buchholzia coriacea; Diabetes; Hepatotoxicity; Oxidative stress; Streptozotocin

Indexed keywords

ALANINE AMINOTRANSFERASE; ALCOHOL; ANTIDIABETIC AGENT; ASPARTATE AMINOTRANSFERASE; BUCHHOLZIA CORIACEA EXTRACT; BUTANOL; CHOLESTEROL; CREATININE; GLIBENCLAMIDE; PLANT EXTRACT; SUPEROXIDE DISMUTASE; THIOBARBITURIC ACID REACTIVE SUBSTANCE; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; UREA;

ACUTE TOXICITY; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BUCHHOLZIA CORIACEA; CAPPARACEAE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIABETES MELLITUS; DRUG ACTIVITY; GLUCOSE BLOOD LEVEL; HYPERGLYCEMIA; HYPOGLYCEMIC ACTIVITY; LIVER DYSFUNCTION; MALE; MOUSE; NONHUMAN; ORGAN WEIGHT; OXIDATIVE STRESS; PLANT SEED; RAT; STREPTOZOCIN DIABETES; TRIACYLGLYCEROL BLOOD LEVEL; UREA BLOOD LEVEL; WEIGHT REDUCTION;

1-BUTANOL; ADMINISTRATION, ORAL; ANIMALS; ANTIOXIDANTS; BLOOD GLUCOSE; CAPPARACEAE; CHEMICAL FRACTIONATION; DIABETES MELLITUS, EXPERIMENTAL; DRUG-INDUCED LIVER INJURY; ETHANOL; HYPOGLYCEMIA; HYPOGLYCEMIC AGENTS; LIVER; MALE; MICE; MICE, INBRED STRAINS; PLANT EXTRACTS; RATS; RATS, WISTAR; SEEDS;

BUCHHOLZIA CORIACEA; CAPPARACEAE; MUS; RATTUS;

EID: 80053284727     PISSN: 09402993     EISSN: 16181433     Source Type: Journal    
DOI: 10.1016/j.etp.2010.05.002     Document Type: Article

References (40)

1. Adaramoye O.A., Adeyemi E.O. Hypoglycaemic and hypolipidemic effects of fractions from Kolaviron, a biflavonoid complex from Garcinia kola in streptozotocin-induced diabetes mellitus rats. J Pharm Pharmacol 2006, 58:121-128.
2. Adjounahum E, Ake Assi L. Plantes Pharmaceutiques de Cote d'Ivoire. Abidjan; 1972. p. 117-8.
3. Ahn T., Yun C.-H., Oh D.-B. Tissue specific effect of ascorbic acid supplement on the expression of cytochrome P450 2EI and oxidative stress in streptozotocin-induced diabetic rats. Toxicol Lett 2006, 166:27-36.
4. Ajaiyeoba E.O., Onocha P.A., Olanrewaju O.T. In vitro anti-helminthic properties of Buchholzia coriacea and Gynandropsis gynandra. Pharm Biol 2001, 39:217-220.
5. Akhtar F.M., Ali M.R. Study of the antidiabetic effect of a compound medicinal plant description in normal and diabetic rabbit. J Pak Med Assoc 1984, 34:239-244.
6. Alderson N.L., Chachich M.E., Frizzell N., Canning P., Metz T.O., Januszewski A.S. Effect of antioxidants and ACE inhibition on chemical modification of proteins and progression of nephropathy in streptozotocin diabetic rat. Diabetologia 2004, 47:1385-1395.
7. Almdal T.P., Vilstrup H. Strict insulin treatment normalizes the organic nitrogen contents and the capacity of urea-N synthesis in experimental diabetes in rats. Diabetes 1988, 31:114-118.
8. Aubréville A. Flore forestière de la Côte d'Ivoire. Centre Tech Forest Trop Nogent 1959, 960.
9. Barham D., Trinder P. An improved color reagent for the determination of blood glucose by the oxidase system. Analyst 1972, 97:142.
10. Bastar I., Seckin S., Uysal M., Toker G.A. Effect of streptozotocin on glutathione and lipid peroxide levels in various tissues of rats. Res Commun Mol Pathol Pharmacol 1998, 102:265-272.
11. Bopanna K.N., Kannan J., Sushman G., Balaraman R., Rathod S.P. Antidiabetic and antihyperlipidaemic effects of neem seed kernel powder on alloxan diabetic rabbits. Indian J Pharmacol 1997, 29:162-167.
12. Bouquet A., Debray M. Plantes Medicinalis de Côte d'Ivoire. Doc Orstrom 1974, 32:63.
13. Tietz textbook of Clinical chemistry 1999, 1835. W. Saunders Company, Philadelphia. 3rd ed. C.A. Burtis, E.R. Ashwood (Eds.).
14. Evans W.C. Trease and Evans pharmacognosy 1989, Balliere Tindall, London. 13th ed.
15. Halliwell B., Gutteridge J.M.C. Oxygen toxicity, oxygen radical transition metals and disease. Biochem J 1984, 219:1-14.
16. Heidland A., Ling H., Vamvakas S., Paczek L. Impaired proteolytic activity as a potential cause of progressive renal disease. Miner Electrolyte Metab 1996, 22:157-161.
17. Irvine J.R. Woody plants of Ghana 1961, Oxford University Press, London, p. 51. 2nd ed.
18. Kakkar R., Mantha S.V., Randhi J., Prasad K., Kalra J. Increased oxidative stress in rat liver and pancrease during progression of streptozotocin-induced diabetes. Clin Sci 1998, 94:623-632.
19. Kamalakannan N., Rukkumani R., Aruna K., Varma P.S., Viswanathan P., Menon V.P. Protective effect of N-acetyl cysteine in carbon tetrachloride-induced hepatotoxicity in rats. Iran J Pharmacol Ther 2005, 4(2):118-123.
20. Kerharo J., Bouquet A. Planter medicinales et toxiquet, de la Cote d'Ivoire et Heute-volta, Ministere de la France d'iytremerm 1950, Office de la Recherche Scientifique Outramer, Paris, p. 289.
21. Lowry O.H., Rosenbrough N.J., Farr A.L., Randall R.J. Protein measurement with Folin phenol reagent. J Biol Chem 1951, 193:265-275.
22. Marklund S. Distribution of CuZn superoxide dismutase and Mn superoxide dismutase in human tissues and extracellular fluids. Acta Physiol Scand Suppl 1980, 492:19-23.
23. Mir S.H., Baqui A., Bhagat R.C., Darzi M.M., Shah A.W. Biochemical and histological study of streptozotocin-induced diabetes mellitus in rabbits. Pak J Nutr 2008, 7(2):359-364.
24. Moller D.E. New drug targets for type 2 diabetic and the metabolic syndrome. Nature 2001, 414:812-827.
25. Moss D.W., Henderson A.R. Clinical enzymology. Tietz textbook of clinical chemistry 1999, 617-721. W. Saunders Company, Philadelphia. 3rd ed. C.A. Burtis, E.R. Ashwood (Eds.).
26. Organisation de Coopération et de Développement Economiques (OCDE) Harmonised integrated hazard classification for human health and environment. Effects of chemical substances as endorsed by the 28th Joint Meeting of the chemicals committee and the working party on chemicals in November, vol. 2 1998, 11.
27. Rabkin R., Schechter P., Shi J.D., Boner G. Protein turnover in the hypertrophy in kidney. Miner Electrolyte Metab 1996, 22:153-156.
28. Rajesh M.G., Latha M.S. Preliminary evaluation of the hepatotoxicity of Kamilari, a polyherbal formulation. J Ethnopharmacol 2004, 91:99-104.
29. Rauter A.P., Martins A., Borges C., Ferreira J., Justino J., Bronze M.R., et al. Liquid chromatography-diode array detection-electrospray ionization mass spectrometry/nuclear magnetic resonance analyses of the anti-hyperglycemic flavonoid extract of Genista tenera: structure elucidation of a flavonoid-C-glycoside. J Chromatogr A 2005, 1089(1-2):59-64.
30. Rifai N., Bachorik P.S., Albers J.J. Lipids, lipoproteins and apolipoproteins. Tietz Textbook of Clinical chemistry 1999, 809-861. W. Saunders Company, Philadelphia. 3rd ed. C.A. Burtis, E.R. Ashwood (Eds.).
31. Senthil K.R., PonMozhi M., Viswanathan P., Nalini N. Activity of Cassia auriculata leaf extract in rats with alcoholic liver injury. J Nutr Biochem 2003, 14:452-458.
32. Shibano M., Kakutani K., Taniguchi M., Yasuda M., Baba K. Antioxidant constituents in the dayflower (Commelina communis L.) and their α-glucosidase-inhibitory activity. J Nat Med 2008, 62(3):349-353.
33. Szkudelski T. The mechanism of alloxan and streptozotocin action in β-cells of the rat pancrease. Physiol Res 2001, 50:536-546.
34. Thirunavukkarasu C., Princevijeyasingh J., Selvendiran K., Sakthisekaran D. Chemopreventive efficacy of selenium against DEN-induced hepatoma in albino rats. Cell Biochem Funct 2001, 19:265-271.
35. Varshney R., Kale R.K. Effect of calmodulin antagonist on radiation induced-lipid peroxidation in microsomes. Int J Rad Biol 1990, 58(5):733-743.
36. Venkatesh S., Dayanand R.G., Madhawa R.B., Ramesh M., Apparao A.V.N. Antihyperglycemic activity of Caralluma. Fitoterapia 2003, 74:274-279.
37. Walker A.R. Usages Pharmaceutiques des plantes spontanus du Gabon, vol. 9 1953, Insitut d'Etudes Centra Fracaines, p. 13-26.
38. Weir G.C., Clore E.T., Zmachiroski C.J., Bonner-Weir S. Islet secretion in a new experiment model for non-insulin dependent diabetes. Diabetes 1981, 30:590-595.
39. World Health Organization. Diabetes mellitus. Fact sheet number 138 and 236: Geneva; 1999.
40. Yokozawa T., Kim H.Y., Cho E.J., Choi J.S., Chung H.Y. Antioxidant effects of Isorhamnetin 3, 7-di-O-β-d-glucopyranoside isolated from mustard leaf (Brassica juncea) in rats with streptozotocin-induced diabetes. J Agric Food Chem 2002, 50(19):5490-5495.